Gallus BioPharmaceuticals
Acquisition by DPx Holdings
- B2B
About Gallus BioPharmaceuticals
Acquired by Patheon, expanding their biologic drug substance business globally with four facilities and over 550 employees.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Berkeley, Missouri, United States
- Founded
- 2011
- Revenue
- $11.9M – $93.8MTamtam estimate
- Website
- patheon.com
Gallus BioPharmaceuticals at a glance
Gallus BioPharmaceuticals is a B2B company in the Biotechnology Research industry, headquartered in Berkeley, Missouri, United States.
Gallus BioPharmaceuticals was founded in 2011.
Gallus BioPharmaceuticals has 51–250 employees.
Gallus BioPharmaceuticals's revenue is $11.9M – $93.8M (Tamtam estimate).
Selling to companies like Gallus BioPharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies